Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...
As the conversation around mental health disorders like depression becomes increasingly normalized, it can also blur the lines between situational feelings of stress, anxiety, and dejection and ...
MedPage Today on MSN
Soda-Major Depression Link; FDA Rejects Rexulti for PTSD; Cobenfy Neutropenia Case
Compared with sham therapy, 12 days of personalized treatment with high-definition transcranial direct current stimulation ...
The FDA has cleared an accelerated protocol for a transcranial magnetic stimulation system in the treatment of depression and ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new data from the Phase 2 SAVITRI™ study, ...
A ketogenic diet (KD) is a feasible adjunctive therapy and is associated with improvements in depression symptoms among young adults with major depressive disorder (MDD), according to a study ...
A new study reports that young adults experienced a 70% reduction in depression symptoms after following a ketogenic diet, ...
AbbVie has agreed to buy bretisilocin, an investigational therapy for major depressive disorder, for up to $1.2 billion in deal that bolsters the biopharmaceutical company's psychiatry pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback